← Every applicant
Zydus FDA Approvals
8 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| DIROXIMEL FUMARATENew drugNov 12, 2025CAPSULE, DELAYED RELEASE, ORAL |
| AMANTADINENew drugAug 26, 2024CAPSULE, EXTENDED RELEASE, ORAL |
| PIMAVANSERINNew drugJan 16, 2024TABLET, ORAL |
| PIMAVANSERINNew drugJan 16, 2024CAPSULE, ORAL |
| OXCARBAZEPINENew drugJul 3, 2023TABLET, ORAL |
| VARENICLINE TARTRATENew drugJun 12, 2023TABLET, ORAL |
| TOPIRAMATENew drugNov 28, 2022CAPSULE, EXTENDED RELEASE, ORAL |
| CARIPRAZINE HYDROCHLORIDENew drugSep 9, 2022CAPSULE, ORAL |